Now Reading
Bahrain approves China’s Sinopharm Covid-19 vaccine

Bahrain approves China’s Sinopharm Covid-19 vaccine

The UAE registered the Sinopharm vaccine after finding it had a 86 per cent efficacy rate

Bahrain approved the registration of the Sinopharm Group Co Ltd. vaccine against the coronavirus, about a week after the United Arab Emirates registered the Chinese-made vaccine.

“Results from Phase III clinical trials showed an 86 per cent efficacy rate, a 99 per cent seroconversion rate of neutralising antibody and 100 per cent effectiveness in preventing moderate and severe cases of Covid-19,” the National Health Regulatory Authority said in a statement on Sunday.

Bahrain has participated in phase III clinical trials, in which more than 7,700 volunteers signed up. Bahrain had previously authorised the emergency use of the vaccine, which was provided to frontline workers in contact with coronavirus patients.

Read: Bahrain approves Covid-19 vaccine for frontline workers

The UAE registered the Sinopharm vaccine after finding it had a 86 per cent efficacy rate, paving the way for a full public use and allowing for a re-opening of the Gulf nation’s economy.

Egypt plans to start the process of inoculation against the coronavirus after receiving the first shipments of Sinopharm vaccine.

You might also like

© 2020 MOTIVATE MEDIA GROUP. ALL RIGHTS RESERVED.

Scroll To Top